Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells.
IL-2 is the primary growth factor for promoting survival and proliferation of activated T cells that occurs following engagement of the Janus Kinase (JAK)1-3/and Signal Transducer and Activator of Transcription (STAT) 5 signaling pathway. STAT5 has two isoforms: STAT5A and STAT5B (commonly referred...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3581501?pdf=render |
id |
doaj-613e43b5c2bc4bcf81b08d0652ddf483 |
---|---|
record_format |
Article |
spelling |
doaj-613e43b5c2bc4bcf81b08d0652ddf4832020-11-25T02:15:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5732610.1371/journal.pone.0057326Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells.Zsuzsanna S NagyJeremy A RossGeorgialina RodriguezBalint L BalintLajos SzelesLaszlo NagyRobert A KirkenIL-2 is the primary growth factor for promoting survival and proliferation of activated T cells that occurs following engagement of the Janus Kinase (JAK)1-3/and Signal Transducer and Activator of Transcription (STAT) 5 signaling pathway. STAT5 has two isoforms: STAT5A and STAT5B (commonly referred to as STAT5) which, in T cells, play redundant roles transcribing cell cycle and survival genes. As such, inhibition of STAT5 by a variety of mechanisms can rapidly induce apoptosis in certain lymphoid tumor cells, suggesting that it and its target genes represent therapeutic targets to control certain lymphoid diseases. To search for these molecules we aligned IL-2 regulated genes detected by Affymetrix gene expression microarrays with the STAT5 cistrome identified by chip-on-ChIP analysis in an IL-2-dependent human leukemia cell line, Kit225. Select overlapping genes were then validated using qRT(2)PCR medium-throughput arrays in human PHA-activated PBMCs. Of 19 putative genes, one key regulator of T cell receptor signaling, PDE4B, was identified as a novel target, which was readily up-regulated at the protein level (3 h) in IL-2 stimulated, activated human PBMCs. Surprisingly, only purified CD8+ primary T-cells expressed PDE4B, but not CD4+ cells. Moreover, PDE4B was found to be highly expressed in CD4+ lymphoid cancer cells, which suggests that it may represent a physiological role unique to the CD8+ and lymphoid cancer cells and thus might represent a target for pharmaceutical intervention for certain lymphoid diseases.http://europepmc.org/articles/PMC3581501?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zsuzsanna S Nagy Jeremy A Ross Georgialina Rodriguez Balint L Balint Lajos Szeles Laszlo Nagy Robert A Kirken |
spellingShingle |
Zsuzsanna S Nagy Jeremy A Ross Georgialina Rodriguez Balint L Balint Lajos Szeles Laszlo Nagy Robert A Kirken Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. PLoS ONE |
author_facet |
Zsuzsanna S Nagy Jeremy A Ross Georgialina Rodriguez Balint L Balint Lajos Szeles Laszlo Nagy Robert A Kirken |
author_sort |
Zsuzsanna S Nagy |
title |
Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. |
title_short |
Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. |
title_full |
Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. |
title_fullStr |
Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. |
title_full_unstemmed |
Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. |
title_sort |
genome wide mapping reveals pde4b as an il-2 induced stat5 target gene in activated human pbmcs and lymphoid cancer cells. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
IL-2 is the primary growth factor for promoting survival and proliferation of activated T cells that occurs following engagement of the Janus Kinase (JAK)1-3/and Signal Transducer and Activator of Transcription (STAT) 5 signaling pathway. STAT5 has two isoforms: STAT5A and STAT5B (commonly referred to as STAT5) which, in T cells, play redundant roles transcribing cell cycle and survival genes. As such, inhibition of STAT5 by a variety of mechanisms can rapidly induce apoptosis in certain lymphoid tumor cells, suggesting that it and its target genes represent therapeutic targets to control certain lymphoid diseases. To search for these molecules we aligned IL-2 regulated genes detected by Affymetrix gene expression microarrays with the STAT5 cistrome identified by chip-on-ChIP analysis in an IL-2-dependent human leukemia cell line, Kit225. Select overlapping genes were then validated using qRT(2)PCR medium-throughput arrays in human PHA-activated PBMCs. Of 19 putative genes, one key regulator of T cell receptor signaling, PDE4B, was identified as a novel target, which was readily up-regulated at the protein level (3 h) in IL-2 stimulated, activated human PBMCs. Surprisingly, only purified CD8+ primary T-cells expressed PDE4B, but not CD4+ cells. Moreover, PDE4B was found to be highly expressed in CD4+ lymphoid cancer cells, which suggests that it may represent a physiological role unique to the CD8+ and lymphoid cancer cells and thus might represent a target for pharmaceutical intervention for certain lymphoid diseases. |
url |
http://europepmc.org/articles/PMC3581501?pdf=render |
work_keys_str_mv |
AT zsuzsannasnagy genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells AT jeremyaross genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells AT georgialinarodriguez genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells AT balintlbalint genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells AT lajosszeles genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells AT laszlonagy genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells AT robertakirken genomewidemappingrevealspde4basanil2inducedstat5targetgeneinactivatedhumanpbmcsandlymphoidcancercells |
_version_ |
1724896176851910656 |